Figure 2: Effect of JNJ-26481585/Doxorubicin and JNJ-26481585/Etoposide cotreatment on BJ fibroblasts.
A, Human BJ fibroblasts were treated with 15 nM of JNJ-26481585 and/or 0.25 μg/ml Doxorubicin for 48 hours. Apoptosis was determined by analysis of DNA fragmentation of PI-stained nuclei using flow cytometry. Mean ± SEM of at least three independent experiments carried out in triplicate are shown. B, Human BJ fibroblasts were treated with 15 nM of JNJ-26481585 and/or 100 μg/ml Etoposide for 48 hours. Apoptosis was determined by analysis of DNA fragmentation of PI-stained nuclei using flow cytometry. Mean ± SEM of at least three independent experiments carried out in triplicate are shown. A, Rh30 cells were treated for 48 hours with 15 nM JNJ-26481585 and/or 0.25 μg/ml Doxorubicin. Cell death was determined by SYTOX® Blue-stained nuclei using flow cytometry. Mean ± SEM of at least three independent experiments carried out in triplicate are shown. B, Rh30 cells were treated for 48 hours with 15 nM JNJ-26481585 and 0.25 μg/ml Doxorubicin, +/-50 μM zVAD.fmk and 60 μM Nec-1s. Cell death was determined by SYTOX® Blue-stained nuclei using flow cytometry. Mean ± SEM of at least three independent experiments carried out in triplicate are shown; **P˂0.01. 
